<SEC-DOCUMENT>0000947871-25-000610-index.html : 20250616
<SEC-HEADER>0000947871-25-000610.hdr.sgml : 20250616
<ACCEPTANCE-DATETIME>20250616073749
ACCESSION NUMBER:		0000947871-25-000610
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250616
DATE AS OF CHANGE:		20250616

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sionna Therapeutics, Inc.
		CENTRAL INDEX KEY:			0002036042
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94871
		FILM NUMBER:		251048541

	BUSINESS ADDRESS:	
		STREET 1:		21 HICKORY DRIVE, SUITE 500
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		617-819-2020

	MAIL ADDRESS:	
		STREET 1:		21 HICKORY DRIVE, SUITE 500
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Qatar Investment Authority
		CENTRAL INDEX KEY:			0001441449
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			S3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		OOREDOO TOWER (BUILDING 14),
		STREET 2:		AL DAFNA ST (STREET 801)
		CITY:			DOHA
		STATE:			S3
		ZIP:			QATAR
		BUSINESS PHONE:		974 441 4466

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 23224
		CITY:			DOHA
		STATE:			S3
		ZIP:			QATAR
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>